Not provided
Not provided
Not provided
Not provided
Not provided
Impossibility to recruit the targeted population
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Efficacy and tolerability of a composition comprising of HMO in a supplement format on colic management: a double-blind, randomized, placebo-controlled trial
This is a double-blinded, randomized, placebo-controlled trial. The purpose of this trial is to investigate the efficacy and tolerability of a composition comprising of HMO in a supplement format in the management of colicky infants aged 2-12 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Liquid oral supplement comprising HMO | Experimental | 2 ampules/day for 21 days |
|
| Placebo | Placebo Comparator | 2 ampules/day for 21 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HMO | Dietary Supplement | Composition comprising of HMO |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Difference in average infant daily crying and fussing duration | Difference in average infant daily crying and fussing duration at the end of the intervention in the Intervention Group (IG) versus the Control Group (CG). The crying and fussing duration is measured using a structured infant crying and fussing diary. | At the end of the intervention period (day 21) |
| Measure | Description | Time Frame |
|---|---|---|
| Modulation of infant gut microbiota (communities of microbes, their taxonomy, strain composition, diversity, ecology, functionalities, and the metabolites produced) | Modulation of infant gut microbiota in the intervention group versus the control group assessed using metagenomics | V1 (day 0), V2 (day 7), and V4 (day 21) |
| Measure | Description | Time Frame |
|---|---|---|
| Duration and number of episodes of infant crying type based on a crying-type classification of the audio recording | Duration and number of episodes of each infant crying type (pain, fussiness, hunger) based on a crying-type classification of the audio recording | 24 hours after V1 (day 0), V2 (day 7), V3 (day 14) and for 3 days prior to V4 (day 21) |
Inclusion criteria:
Infants 2 weeks - 12 weeks of age at enrolment
Infants diagnosed with colic according to Rome IV criteria: Diagnostic criteria for research purposes (infant must meet all Rome IV criteria):
Term infants (≥ 37 weeks) generally healthy with normal birth weight (≥2.5kg) and singleton born
Predominantly formula fed* (formula fed ≥ 80% of the time) for at least 7 days before randomization and the choice of formula feeding has been made by the parents before the beginning of the trial.
Infants who have been on the same formula for the past 5 days
Signed informed consent obtained for infant's and parents'/Legally Acceptable Representative (LAR) participation in the study
Parent/LAR of infant agrees not to enroll infant in another interventional clinical research study while participating in this study
Parent of the infant/LAR is willing and able to fulfill the requirements of the study protocol
Parent of infant can be contacted throughout the study
Exclusion criteria:
Presence of any congenital condition and/or previous or current illness/infection and (or) medication use that could interfere with the main study outcomes.
Clinical evidence of chronic illness or gastrointestinal disorders, major medical problems (e.g. ill, immunocompromised, major developmental or genetic abnormality).
Known cow's milk protein allergy, lactose intolerance, or galactosaemia; including presence of any allergic manifestations.
Received any special formula (e.g. lactose-free, hydrolyzed protein) within 5 days before randomization or switched formulas within 5 days before randomization.
Received any of the following products/medication within 5 days before randomization:
Other infant(s) <6months of age living in the same household.
Current participation in another interventional clinical trial.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ospedale Pediatrico Giovanni XXIII, Policlinico di Bari | Bari | 70126 | Italy | |||
| ASST FBF Sacco |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003085 | Colic |
| ID | Term |
|---|---|
| D007232 | Infant, Newborn, Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
| ID | Term |
|---|---|
| D006279 | Health Maintenance Organizations |
| D010166 | Palliative Care |
| ID | Term |
|---|---|
| D008329 | Managed Care Programs |
| D007348 | Insurance, Health |
| D007341 | Insurance |
| D005381 | Financing, Organized |
Not provided
Not provided
Randomized, double-blinded, placebo-controlled, parallel-arm, intervention study
Not provided
Not provided
Randomization will be carried out using iMedidata Randomization Trial Supply Management System with the dynamic allocation algorithm.
| Placebo |
| Dietary Supplement |
Placebo supplementation having the same appearance and dosing regimen as the intervention |
|
| Parental reassurance and support | Behavioral | Both groups will receive standardized written materials to provide parental reassurance and support, in alignment with local clinical practice |
|
| Difference in average infant daily crying duration |
Difference in average infant daily crying duration at the end of the intervention in the IG versus the CG assessed using a structured infant crying and fussing diary. |
| Change from baseline (V1) to intervention end (V4) |
| Difference in average infant daily fussing duration | Difference in average infant daily fussing duration at the end of the intervention in the IG versus the CG assessed using a structured infant crying and fussing diary. | Change from baseline (V1) to intervention end (V4) |
| Difference in average infant daily crying and fussing duration in the IG | Difference in average infant daily crying duration and fussing duration combined from baseline (V1) to intervention end (V4) in the IG assessed using a structured infant crying and fussing diary. | Change from baseline (V1) to intervention end (V4) |
| Difference in average infant daily crying duration in the Intervention group | Difference in average infant daily crying duration from baseline (V1) to intervention end (V4) in the Intervention group assessed using a structured infant crying and fussing diary. | Change from baseline (V1) to intervention end (V4) |
| Difference in average infant daily fussing duration in the Intervention group | Difference in average infant daily fussing duration from baseline (V1) to intervention end (V4) in the interventional group assessed using a structured infant crying and fussing diary. | Change from baseline (V1) to intervention end (V4) |
| Infant daily crying and fussing duration assessed longitudinally | Infant daily crying and fussing duration combined assessed longitudinally across the intervention assessed using a structured infant crying and fussing diary. | Longitudinal changes across specific visits V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Infant crying/fussing per 24 hours | Episodes of infant crying/fussing per 24 hours assessed using a structured infant crying and fussing diary. | At specific visits V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Percentage of children achieving a reduction in daily crying and fussing | Percentage of children achieving a reduction in daily crying, fussing, crying and fussing time combined of ≤ 25 % and ≤ 50 % assessed using a structured infant crying and fussing diary. | At specific visits V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Incidence of infantile colic | Incidence of infantile colic assessed using a structured infant crying and fussing diary. | At specific visits V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Parental perception of colic severity | Parental perception of colic severity assessed using a 10-cm visual analog scale (VAS) | At specific visits V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Overall GI tolerance and individual GI symptoms | Overall infant GI tolerance and individual GI and GI-related symptoms (stooling, spitup/ vomiting, gassiness, crying, fussiness) assessed using IGSQ-13 | V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Overall GI tolerance and individual GI symptoms | Change in IGSQ-13 scores assessed using IGSQ-13 | Baseline to intervention end (day 21) |
| Overall GI tolerance and individual GI symptoms | Functional GI symptoms (regurgitation, consistency of stools), crying, allergic symptoms (atopic eczema) and respiratory symptoms assessed using CoMiSS | At V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Overall GI tolerance and individual GI symptoms | Change in CoMiSS scores assessed using CoMiSS | From baseline to intervention end (day 21) |
| Overall GI tolerance and individual GI symptoms | Stool consistency, spitting up/vomiting and flatulence assessed using 1-day retrospective GI diary at V1 (day 0) and prospective 3-Day GI symptom diary diaries at home (H2, H3 and H4) just prior to V2 (day 7), V3 (day 14) and V4 (day 21) | 1-day retrospective GI diary at V1 (day 0) and prospective 3-Day GI symptom diary diaries at home (H2, H3 and H4) just prior to V2 (day 7), V3 (day 14) and V4 (day 21) |
| Infant sleep | Infant sleep duration and nighttime wakings per 24 hours assessed using Brief infant sleep questionnaire (BISQ) | V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Infant Quality of life | Infant quality of life assessed using an Infant Quality of Life instrument. The tool includes IQI includes questions on 7 health items such as sleeping, crying, feeding , skin, breathing, playfulness and Interaction, and stooling. Each item consists of 4 levels, most of which are ranked by severity. | V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Parental and family quality of life | Parental/family quality of life will be assessed using a Quality of Life Visual Analog Scale that rates the parent / family's quality of life based on a 10-point Likert scale. | V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Infant fecal gut microbiota | Microbiome of fecal samples to investigate the communities of microbes, their taxonomy, strain composition, diversity, ecology, functionalities, and the metabolites produced assessed using metagenomics. | V1 (day 0), V2 (day 7), and V4 (day 21) |
| Fecal metabolism | Fecal metabolism (pH, organic acids) | V1 (day 0), V2 (day 7), and V4 (day 21) |
| Fecal markers of inflammation calprotectin | Inflammation biomarkers calprotectin assessed using ELISA. | V1 (day 0) and V4 (day 21) |
| Fecal markers of inflammation lipocalin | Inflammation biomarkers lipocalin assessed using ELISA. | V1 (day 0) and V4 (day 21) |
| Infant anthropometry weight | Weight in grams | V1 (day 0), V2 (day 7), V3 (day 14) (optional if V3 is a phone call) and V4 (day 21) |
| Infant anthropometry length | Length in cm | V1 (day 0), V2 (day 7), V3 (day 14) (optional if V3 is a phone call) and V4 (day 21) |
| Infant anthropometry head circumference | Head circumference in cm | V1 (day 0), V2 (day 7), V3 (day 14) (optional if V3 is a phone call) and V4 (day 21) |
| Infant anthropometry weight gain | Weight gain in g/d | V1 (day 0), V2 (day 7), V3 (day 14) (optional if V3 is a phone call) and V4 (day 21) |
| Infant anthropometry length gain | Length gain in cm/d | V1 (day 0), V2 (day 7), V3 (day 14) (optional if V3 is a phone call) and V4 (day 21) |
| Infant illness and infection and medication usage | Data collected using a calendar-based electronic Infant Illness Diary (IID) | V1 (day 0) until V4 (day 21) |
| Proportion of children with a specific crying type based on a crying-type classification of the audio recording |
Proportion of children with a specific crying type (pain, fussiness, hunger) based on a crying-type classification of the audio recording |
| 24 hours after V1 (day 0), V2 (day 7), V3 (day 14) and for 3 days prior to V4 (day 21) |
| Duration of crying based on a crying-type classification of the audio recording | Duration of crying based on a crying-type classification of the audio recording | 24 hours after V1 (day 0), V2 (day 7), V3 (day 14) and for 3 days prior to V4 (day 21) |
| Duration of fussing based on a crying-type classification of the audio recording | Duration of fussing based on a crying-type classification of the audio recording | 24 hours after V1 (day 0), V2 (day 7), V3 (day 14) and for 3 days prior to V4 (day 21) |
| Duration of crying and fussing combined based on a crying-type classification of the audio recording | Duration of crying and fussing combined based on a crying-type classification of the audio recording | 24 hours after V1 (day 0), V2 (day 7), V3 (day 14) and for 3 days prior to V4 (day 21) |
| Crying and fussing comparison between the structured infant crying and fussing diary and the crying-type classification of the recording of infant crying/fussing across the intervention | Infant daily crying and fussing duration compared between the structured infant crying and fussing diary and the crying-type classification of the recording of infant crying/fussing across the intervention | V1 (day 0), V2 (day 7), V3 (day 14) and V4 (day 21) |
| Maternal Postpartum depression/ anxiety | Maternal postpartum depressive and anxiety symptoms assessed using an Edinburgh postnatal depression scale (EPDS) | V1 (day 0) and V4 (day 21) |
| Milan |
| Italy |
| AOUP Paolo Giaccone | Palermo | Italy |
| Azienda Ospedaliero -Universitaria Pisana | Pisa | Italy |
| Centro de Salud El Ranero | Murcia | 30009 | Spain |
| Hospital Clínico Universitario de Santiago de Compostela | Santiago de Compostela | 15706 | Spain |
| Unidad de Estudios e Investigación IHP | Seville | 41014 | Spain |
| D004467 |
| Economics |
| D004472 | Health Care Economics and Organizations |
| D017061 | Prepaid Health Plans |
| D006123 | Group Practice |
| D011364 | Professional Practice |
| D009934 | Organization and Administration |
| D006298 | Health Services Administration |
| D003695 | Delivery of Health Care |
| D010346 | Patient Care Management |
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |